數位糖尿病管理市場:各類型，各產品，各地區- 市場規模，佔有率，展望，機會分析，2023年～2030年

Digital Diabetes Management Market, By Type and By Product, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月14日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態:

糖尿病負擔的增加、老年人口的增加、糖尿病管理設備中人工智能（AI）的引入、對數位糖尿病管理設備的需求不斷增加以及人們對糖尿病護理和技術先進的糖尿病管理設備的好處的認識不斷提高是預計的主要因素在預測期內推動全球數位糖尿病管理市場的增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球數位糖尿病管理市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球數位糖尿病管理市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球數位糖尿病管理市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球數位糖尿病管理市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Digital diabetes management devices, like smart insulin pens, smart insulin pumps, smart glucose meter, and continuous blood glucose monitoring devices, help people with diabetes (type I and II) to monitor and manage their glucose levels. Thus, with the increasing prevalence of diabetes across the globe, the demand for technologically advanced diabetes management devices (digital diabetes management devices) is also increasing with a rapid pace.

Market Dynamics:

Rise in burden of diabetes, growing geriatric population, introduction of artificial intelligence (AI) in diabetes management devices, increasing demand for digital diabetes management devices, and increasing awareness among people about diabetes care and benefits of technologically advanced diabetes management devices are major factors expected to propel the growth of the global digital diabetes management market over the forecast period.

For instance, in November 2022, Eli Lilly and Company (LLY) planned to rollout first connected platform, the Tempo Personalized Diabetes Management Platform, in the U.S. The platform aims to help individuals living with type 1 or type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins.

Moreover, in March 2022, India Medtronic Private Limited announced the launch of the MiniMed 780G system in India. The MiniMed 780G system is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years.

Key features of the study:

This report provides in-depth analysis of the global digital diabetes management market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global digital diabetes management market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, Terumo Corporation, Dexcom, Inc., and Becton, Dickinson and Company, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global digital diabetes management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital diabetes management market.

Detailed Segmentation:

Global Digital Diabetes Management Market, By Type:
- Handheld Devices
- Wearable Devices
Global Digital Diabetes Management Market, By Product:
- Continuous Blood Glucose Monitoring Systems
- Smart Glucose Meter
- Smart Insulin Pumps
- Smart Insulin Pens
- Apps
Global Digital Diabetes Management Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Acon Laboratories, Inc.
- Bayer AG
- F. Hoffmann-la Roche Ltd.
- Johnson and Johnson
- Medtronic Plc
- Novo Nordisk A/S
- Terumo Corporation
- Dexcom, Inc.
- Becton, Dickinson and Company

Market Dynamics
- Increasing prevalence of diabetes around the world
- High cost of digital diabetes management devices
- Increasing demand for digital management devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Digital Diabetes Management Mask Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Digital Diabetes Management Market, By Type, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Handheld Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Digital Diabetes Management Market, By Product, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Continuous Blood Glucose Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Smart Glucose Meter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Smart Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Smart Insulin Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Digital Diabetes Management Market, By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)

8. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Acon Laboratories, Inc.
Bayer AG
F. Hoffmann-la Roche Ltd.
Johnson and Johnson
Medtronic Plc
Novo Nordisk A/S
Terumo Corporation
Dexcom, Inc.
Becton, Dickinson and Company
Analyst Views